首页> 外国专利> Derivatives of 3,4-dihydro - 2H - 1,4 benzo oxazine and thiazine as CETP inhibitors

Derivatives of 3,4-dihydro - 2H - 1,4 benzo oxazine and thiazine as CETP inhibitors

机译:CETP抑制剂3,4-二氢-2H-[1,4]苯并恶嗪和噻嗪的衍生物

摘要

Refers to compounds derived from 3,4-dihydro - 2H - [1,4] benzo oxazine and thiazine of formula (i), where l is Covalent or u; X is o or s; Q is aryl or heteroaryl (C6 C10) of 5 to 6 members, N and M are 0 to 3; r1 is alkyl (C1 - C10), alquenilo (C2 C10), among other option is phenyl or substituted At present, Halo; R2 is alkyl, Hydroxy, alkoxy or CN, (c1-c4) Halogenated,Among others; R3 is alkyl (c1-c4), alquenilo (c2-c4), among other alkyl; R4 (C1 - C10) is optionally substituted with 1 to 3 members of Halo, Hydroxy, Oxo, among others.Are selected: 1,1,1 trifluoro - - 3 - [3 - [3 - (1,1,2,2 - tetrafluoro - ethoxy) - phenyl] - 8 - (trifluoromethoxy) - phenyl) - 2,3 dihydro - benzo [1,4] oxazin - 4-yl] propan-2-ol, (3S) - 2.3 dihydro - 3 - [3 - (1,1,2,3 - tetrafluoroetoxi) phenyl] - 2 - [3 - (trifluoromethoxy) phenyl] - (trifluoromethyl) - 4H - 1.4 - benzoxazina - 4 - ethanol, among others. You. It also relates to a Pharmaceutical composition.These compounds are CETP inhibitors and are useful in the treatment of Atherosclerosis, Hyper LDL - cholesterol, dyslipidemia, diabetes, obesity, cardiovascular diseases and related
机译:指衍生自式(i)的3,4-二氢-2H- [1,4]苯并恶嗪和噻嗪的化合物,其中l为共价或u; X是o或s; Q是5至6元的芳基或杂芳基(C 6 -C 10),N和M为0至3; r1是烷基(C1-C10),alquenilo(C2-C10),除其他选择外是苯基或被取代。 R2为烷基,羟基,烷氧基或CN,(c1-c4)卤代的,以及其他; R3为烷基(c1-c4),alquenilo(c2-c4),以及其他烷基; R4(C1-C10)可选地被1-3个Halo,Hydroxy,Oxo等成员取代。被选择:1,1,1三氟--3-[3-[3-(1,1,2, 2-四氟-乙氧基)-苯基]-8-(三氟甲氧基)-苯基)-2,3二氢-苯并[1,4]恶嗪-4-基]丙烷-2-醇,(3S)-2.3二氢-3 -[3-(1,1,2,3-四氟乙氧基)苯基] -2- [3-(三氟甲氧基)苯基]-(三氟甲基)-4H-1.4-苯并嗪-4-乙醇。您。还涉及药物组合物。这些化合物是CETP抑制剂,可用于治疗动脉粥样硬化,高LDL-胆固醇,血脂异常,糖尿病,肥胖症,心血管疾病及相关疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号